Literature DB >> 2551358

Partial protection of oncogene, anti-sense oligodeoxynucleotides against serum nuclease degradation using terminal methylphosphonate groups.

D M Tidd1, H M Warenius.   

Abstract

Under certain circumstances sequence-specific inhibition of gene expression may be achieved in intact cells using exogenous anti-sense oligodeoxynucleotides. The efficacy of this approach to investigating gene function is limited in part by the rapid serum nuclease mediated degradation of oligodeoxynucleotides in culture media. In order to determine the relative contributions of 3'-exonuclease, 5'-exonuclease and endonuclease activity in fetal calf serum to oligodeoxynucleotide destruction, we have tested chimeric N-ras anti-sense sequence molecules protected against exonuclease attack with terminal methylphosphonate diester linkages. An 18-mer with two methylphosphonate diester linkages at the 3'-terminus, a 20-mer with two methylphosphonate diester groups at both ends, and the 16-mer 3'-methylphosphonate monoester components of their respective piperidine hydrolysates were totally resistant to venom phosphodiesterase, whereas the 16-mer 3'-hydroxyl components of the hydrolysates were rapidly degraded. Both the chimeric oligodeoxynucleotides and 3'-methylphosphonate monoesters were considerably more stable than normal 3'-hydroxyl oligodeoxynucleotides at 37 degrees C in McCoy's 5A medium containing 15% heat inactivated fetal calf serum. Typically 20-30% of the former (initial concentration 10-100 microM) remained intact at 20 h as compared to the latter which were 88-100% degraded in 4 h and undetectable at 20 h. We conclude that a 3'-phosphodiesterase activity is a predominant nuclease responsible for oligodeoxynucleotide degradation by fetal calf serum, and that for cell culture studies, significant protection of oligodeoxynucleotides may be achieved by incorporating 3'-terminal methylphosphonate diester or even monoester end groups.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2551358      PMCID: PMC2247198          DOI: 10.1038/bjc.1989.283

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

1.  Stepwise degradation of polyribonucleotides.

Authors:  G Keith; P T Gilham
Journal:  Biochemistry       Date:  1974-08-13       Impact factor: 3.162

2.  Preparation of oligodeoxyribonucleoside methylphosphonates on a polystyrene support.

Authors:  P S Miller; C H Agris; A Murakami; P M Reddy; S A Spitz; P O Ts'o
Journal:  Nucleic Acids Res       Date:  1983-09-24       Impact factor: 16.971

3.  Effects of bis(6-mercaptopurine-9-beta-D-ribofuranoside)-5',5"-phosphate and its butyryl derivative on mouse leukaemia L1210 and a 6-mercaptopurine-resistant subline in culture.

Authors:  D M Tidd; H P Johnston; I Gibson
Journal:  Biochem Pharmacol       Date:  1982-09-15       Impact factor: 5.858

4.  Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide.

Authors:  P C Zamecnik; M L Stephenson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

5.  Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA.

Authors:  P C Zamecnik; J Goodchild; Y Taguchi; P S Sarin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

6.  Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5.

Authors:  C C Smith; L Aurelian; M P Reddy; P S Miller; P O Ts'o
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

7.  Oligothymidylate analogues having stereoregular, alternating methylphosphonate/phosphodiester backbones. Synthesis and physical studies.

Authors:  P S Miller; N Dreon; S M Pulford; K B McParland
Journal:  J Biol Chem       Date:  1980-10-25       Impact factor: 5.157

8.  Characterization of sequence-specific oligodeoxyribonucleoside methylphosphonates and their interaction with rabbit globin mRNA.

Authors:  A Murakami; K R Blake; P S Miller
Journal:  Biochemistry       Date:  1985-07-16       Impact factor: 3.162

9.  Site specific enzymatic cleavage of RNA.

Authors:  H Donis-Keller
Journal:  Nucleic Acids Res       Date:  1979-09-11       Impact factor: 16.971

10.  Biochemical and biological effects of nonionic nucleic acid methylphosphonates.

Authors:  P S Miller; K B McParland; K Jayaraman; P O Ts'o
Journal:  Biochemistry       Date:  1981-03-31       Impact factor: 3.162

View more
  20 in total

1.  Increased specificity for antisense oligodeoxynucleotide targeting of RNA cleavage by RNase H using chimeric methylphosphonodiester/phosphodiester structures.

Authors:  R V Giles; D M Tidd
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

Review 2.  shRNA and siRNA delivery to the brain.

Authors:  William M Pardridge
Journal:  Adv Drug Deliv Rev       Date:  2007-03-16       Impact factor: 15.470

3.  Comparison of several linear fluorophore- and quencher-conjugated oligomer duplexes for stability, fluorescence quenching, and kinetics in vitro and in vivo in mice.

Authors:  Surong Zhang; Guozheng Liu; Xinrong Liu; Dongguang Yin; Shuping Dou; Jiang He; Mary Rusckowski; Donald J Hnatowich
Journal:  Bioconjug Chem       Date:  2007-05-19       Impact factor: 4.774

4.  Modified deoxyoligonucleotides stable to exonuclease degradation in serum.

Authors:  J P Shaw; K Kent; J Bird; J Fishback; B Froehler
Journal:  Nucleic Acids Res       Date:  1991-02-25       Impact factor: 16.971

5.  Gene delivery through the use of a hyaluronate-associated intracellularly degradable crosslinked polyethyleneimine.

Authors:  Peisheng Xu; Griffin K Quick; Yoon Yeo
Journal:  Biomaterials       Date:  2009-07-25       Impact factor: 12.479

6.  Radiolabeled oligonucleotides for antisense imaging.

Authors:  Arun K Iyer; Jiang He
Journal:  Curr Org Synth       Date:  2011-08-01       Impact factor: 1.975

7.  Effects of RNA secondary structure on cellular antisense activity.

Authors:  T A Vickers; J R Wyatt; S M Freier
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

8.  4'-Thio-oligo-beta-D-ribonucleotides: synthesis of beta-4'-thio-oligouridylates, nuclease resistance, base pairing properties, and interaction with HIV-1 reverse transcriptase.

Authors:  L Bellon; J L Barascut; G Maury; G Divita; R Goody; J L Imbach
Journal:  Nucleic Acids Res       Date:  1993-04-11       Impact factor: 16.971

9.  Ex vivo regulation of specific gene expression by nanomolar concentration of double-stranded dumbbell oligonucleotides.

Authors:  C Clusel; E Ugarte; N Enjolras; M Vasseur; M Blumenfeld
Journal:  Nucleic Acids Res       Date:  1993-07-25       Impact factor: 16.971

10.  Inhibition of transcription by platinated triplex-forming oligonucleotides.

Authors:  Mindy K Graham; Paul S Miller
Journal:  J Biol Inorg Chem       Date:  2012-09-11       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.